Cargando…

Repurposing dyphylline as a pan-coronavirus antiviral therapy

BACKGROUND: In the last two decades, the world has witnessed the emergence of zoonotic corona viruses (CoVs), which cause mild to severe respiratory diseases in humans. Human coronaviruses (HCoVs), mainly from the alpha-CoV and beta-CoV genera, have evolved to be highly pathogenic, such as SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yining, Rajpoot, Sajjan, Li, Pengfei, Lavrijsen, Marla, Ma, Zhongren, Hirani, Nik, Saqib, Uzma, Pan, Qiuwei, Baig, Mirza S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048854/ https://www.ncbi.nlm.nih.gov/pubmed/35387498 http://dx.doi.org/10.4155/fmc-2021-0311

Ejemplares similares

Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions
por: Wang, Yining, et al.
Publicado: (2022)

Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models
por: Wang, Yining, et al.
Publicado: (2021)

Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses
por: Li, Jiajing, et al.
Publicado: (2023)

Repurposing Thioridazine (TDZ) as an anti-inflammatory agent
por: Baig, Mirza S., et al.
Publicado: (2018)

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
por: Wang, Yining, et al.
Publicado: (2021)

Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
por: Baig, Mirza S., et al.
Publicado: (2020)

Immunosuppressants exert differential effects on pan‐coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir
por: Wang, Yining, et al.
Publicado: (2023)

Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations
por: Solanki, Kundan, et al.
Publicado: (2022)

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2
por: Ohishi, Tomokazu, et al.
Publicado: (2022)

Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids
por: Li, Pengfei, et al.
Publicado: (2022)

TIRAP in the Mechanism of Inflammation
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein
por: Alagumuthu, Manikandan, et al.
Publicado: (2020)

Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19
por: Rajpoot, Sajjan, et al.
Publicado: (2020)

Does Cross-neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses?
por: Ma, Zhongren, et al.
Publicado: (2020)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients
por: Li, Pengfei, et al.
Publicado: (2021)

Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses
por: Ma, Zhongren, et al.
Publicado: (2020)

Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response
por: Wang, Yining, et al.
Publicado: (2023)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Recapitulating hepatitis E virus–host interactions and facilitating antiviral drug discovery in human liver–derived organoids
por: Li, Pengfei, et al.
Publicado: (2022)

Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseases
por: Uzma, Saqib, et al.
Publicado: (2016)

Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context
por: Li, Pengfei, et al.
Publicado: (2020)

TIRAP-mediated activation of p38 MAPK in inflammatory signaling
por: Rajpoot, Sajjan, et al.
Publicado: (2022)

Indomethacin-based PROTACs as pan-coronavirus antiviral agents
por: Desantis, Jenny, et al.
Publicado: (2021)

Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses
por: Li, Xue, et al.
Publicado: (2021)

Identification of potential pan-coronavirus therapies using a computational drug repurposing platform
por: Hwang, Woochang, et al.
Publicado: (2022)

Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity
por: Mori, Mattia, et al.
Publicado: (2023)

Estimating the global prevalence of hepatitis E virus in swine and pork products
por: Li, Pengfei, et al.
Publicado: (2021)

Distinct effectiveness in containing COVID-19 epidemic: Comparative analysis of two cities in China by mathematical modeling
por: Ji, Yunpeng, et al.
Publicado: (2021)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

The expanding roles of neuronal nitric oxide synthase (NOS1)
por: Solanki, Kundan, et al.
Publicado: (2022)

Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-Analyses
por: Ma, Zhongren, et al.
Publicado: (2020)

Phytochemicals as modulators of M1-M2 macrophages in inflammation
por: Saqib, Uzma, et al.
Publicado: (2018)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Identification of antiviral antihistamines for COVID-19 repurposing
por: Reznikov, Leah R., et al.
Publicado: (2021)

Potential for the Repurposing of Adamantane Antivirals for COVID-19
por: Butterworth, Roger F.
Publicado: (2021)

Repurposing Antifungals for Host-Directed Antiviral Therapy?
por: Schloer, Sebastian, et al.
Publicado: (2022)

Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
por: Watashi, Koichi
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_logop9m61c25viftk7a1crqf8h